Scholarlink

Background <p>Chronic tendinopathies are common causes of persistent musculoskeletal pain. In refractory cases, pathological hypervascularization and neo-innervation play a&#xa0;key role in pain generation. Transarterial microembolization (TAME) aims to reduce this abnormal vascularity using a&#xa0;minimally invasive approach.</p> Purpose <p>This review summarizes current evidence regarding the efficacy and safety of TAME in selected tendinopathies.</p> Materials and methods <p>A&#xa0;narrative review of recent literature on TAME for adhesive capsulitis, medial and lateral epicondylitis, Achilles tendinopathy, and plantar fasciitis was conducted, focusing on technical aspects, embolic agents, and clinical outcomes.</p> Results <p>Available studies consistently demonstrate significant pain reduction and functional improvement following TAME across all indications. The strongest evidence exists for adhesive capsulitis and Achilles tendinopathy, with reported clinical success rates of approximately 80–90%. Procedures are typically performed catheter-guided using a&#xa0;superselective approach and temporary embolic agents, most commonly imipenem/cilastatin. No major complications have been reported.</p> Conclusion <p>TAME represents a&#xa0;safe and effective minimally invasive treatment option for selected refractory tendinopathies and may bridge the gap between conservative management and surgery. Further randomized controlled trials are required to define long-term outcomes and optimal patient selection.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Transarterielle Mikroembolisation bei Tendinopathien

  • 期刊论文

  • 发表日期：

    2026年4月13日

查看全文
  • A. Taheri Amin,
  • Peter Minko

摘要

Background

Chronic tendinopathies are common causes of persistent musculoskeletal pain. In refractory cases, pathological hypervascularization and neo-innervation play a key role in pain generation. Transarterial microembolization (TAME) aims to reduce this abnormal vascularity using a minimally invasive approach.

Purpose

This review summarizes current evidence regarding the efficacy and safety of TAME in selected tendinopathies.

Materials and methods

A narrative review of recent literature on TAME for adhesive capsulitis, medial and lateral epicondylitis, Achilles tendinopathy, and plantar fasciitis was conducted, focusing on technical aspects, embolic agents, and clinical outcomes.

Results

Available studies consistently demonstrate significant pain reduction and functional improvement following TAME across all indications. The strongest evidence exists for adhesive capsulitis and Achilles tendinopathy, with reported clinical success rates of approximately 80–90%. Procedures are typically performed catheter-guided using a superselective approach and temporary embolic agents, most commonly imipenem/cilastatin. No major complications have been reported.

Conclusion

TAME represents a safe and effective minimally invasive treatment option for selected refractory tendinopathies and may bridge the gap between conservative management and surgery. Further randomized controlled trials are required to define long-term outcomes and optimal patient selection.